Related references
Note: Only part of the references are listed.Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data
Nadezhda T. Doncheva et al.
JOURNAL OF PROTEOME RESEARCH (2019)
The Reactome Pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2018)
miR147b: A novel key regulator of interleukin 1 beta-mediated inflammation in human astrocytes
Jackelien van Scheppingen et al.
GLIA (2018)
MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas
Anika Bongaarts et al.
Oncotarget (2018)
Increased expression of matrix metalloproteinase 3 can be attenuated by inhibition of microRNA-155 in cultured human astrocytes
Anatoly Korotkov et al.
JOURNAL OF NEUROINFLAMMATION (2018)
MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b
Heather Marion Ames et al.
MODERN PATHOLOGY (2017)
D LAMTOR/Ragulator is a negative regulator of Arl8b-and BORC-dependent late endosomal positioning
Przemyslaw A. Filipek et al.
JOURNAL OF CELL BIOLOGY (2017)
Current Development Status of MEK Inhibitors
Ying Cheng et al.
MOLECULES (2017)
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients
John C. Kingswood et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling
Mariana E. G. de Araujo et al.
SCIENCE (2017)
The genomic landscape of tuberous sclerosis complex
Katie R. Martin et al.
NATURE COMMUNICATIONS (2017)
Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
Anika Bongaarts et al.
ONCOTARGET (2017)
Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
James D. Mills et al.
SCIENTIFIC REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
mTOR and MAPK: from localized translation control to epilepsy
Helena F. Pernice et al.
BMC NEUROSCIENCE (2016)
Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats
Yiye Shao et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Long-term treatment of epilepsy with everolimus in tuberous sclerosis
Darcy A. Krueger et al.
NEUROLOGY (2016)
Management of side effects of mTOR inhibitors in tuberous sclerosis patients
Krzysztof Sadowski et al.
PHARMACOLOGICAL REPORTS (2016)
Everolimus for Subependymal Giant Cell Astrocytoma: 5-Year Final Analysis
David N. Franz et al.
ANNALS OF NEUROLOGY (2015)
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Manuele Rebsamen et al.
NATURE (2015)
Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex
Bo Zhang et al.
NEUROBIOLOGY OF DISEASE (2015)
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Shuyu Wang et al.
SCIENCE (2015)
Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex
Sergiusz Jowiak et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2015)
Inhibition of ERK1/2 signaling prevents epileptiform behavior in rats prone to audiogenic seizures
Margarita V. Glazova et al.
JOURNAL OF NEUROCHEMISTRY (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Severity of manifestations in tuberous sclerosis complex in relation to genotype
Sanjeev V. Kothare et al.
EPILEPSIA (2014)
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
David Neal Franz et al.
LANCET ONCOLOGY (2014)
Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy
Jan A. Gorter et al.
NEUROBIOLOGY OF DISEASE (2014)
Epilepsy Related to Developmental Tumors and Malformations of Cortical Development
Eleonora Aronica et al.
NEUROTHERAPEUTICS (2014)
Surgical Treatment of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex Patients
Katarzyna Kotulska et al.
PEDIATRIC NEUROLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Fetal Brain Lesions in Tuberous Sclerosis Complex: TORC1 Activation and Inflammation
Avanita S. Prabowo et al.
BRAIN PATHOLOGY (2013)
Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Katarzyna Kotulska et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
Darcy A. Krueger et al.
NEUROLOGY (2013)
Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods
Leif Varemo et al.
NUCLEIC ACIDS RESEARCH (2013)
A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients
Fabiana Martins et al.
ORAL ONCOLOGY (2013)
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Hope Northrup et al.
PEDIATRIC NEUROLOGY (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Malformations of Cortical Development
Eleonora Aronica et al.
BRAIN PATHOLOGY (2012)
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1
Liron Bar-Peled et al.
CELL (2012)
GENCODE: The reference human genome annotation for The ENCODE Project
Jennifer Harrow et al.
GENOME RESEARCH (2012)
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Christian C. Dibble et al.
MOLECULAR CELL (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
NMDA preconditioning protects against quinolinic acid-induced seizures via PICA, PI3K and MAPK/ERK signaling pathways
Bruno de Araujo Herculano et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development
Emanuele Zurolo et al.
BRAIN (2011)
miRWalk - Database: Prediction of possible miRNA binding sites by walking the genes of three genomes
Harsh Dweep et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2011)
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Reactome: a database of reactions, pathways and biological processes
David Croft et al.
NUCLEIC ACIDS RESEARCH (2011)
Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic Implications
Magdalena Ewa Tyburczy et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Gene Expression Analysis of Tuberous Sclerosis Complex Cortical Tubers Reveals Increased Expression of Adhesion and Inflammatory Factors
Karin Boer et al.
BRAIN PATHOLOGY (2010)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
BioMart - biological queries made easy
Damian Smedley et al.
BMC GENOMICS (2009)
Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature
M. E. A. P. M. Adriaensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
Ruifang Mi et al.
JOURNAL OF GENETICS AND GENOMICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
J. M. Ruijter et al.
NUCLEIC ACIDS RESEARCH (2009)
Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex
K. Boer et al.
EPILEPSY RESEARCH (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
ERK activation causes epilepsy by stimulating NMDA receptor activity
Abdolrahman S. Nateri et al.
EMBO JOURNAL (2007)
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase-mediated mTOR activation in tuberous sclerosis and human cancer
Li Ma et al.
CANCER RESEARCH (2007)
Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: When should we operate?
Sandrine de Ribaupierre et al.
NEUROSURGERY (2007)
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
DN Franz et al.
ANNALS OF NEUROLOGY (2006)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
Li Ma et al.
CELL (2006)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
L Ma et al.
CELL (2005)
Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions
S Han et al.
CANCER RESEARCH (2004)
Brain abnormalities in tuberous sclerosis complex
FJ DiMario
JOURNAL OF CHILD NEUROLOGY (2004)
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytornas:: Biallelic inactivation of TSC1 or TSC2 leads to rnTOR activation
JA Chan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Subependymal giant cell tumors in tuberous sclerosis complex
S Goh et al.
NEUROLOGY (2004)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Subependymal giant cell astrocytoma in children with tuberous sclerosis
V Cuccia et al.
CHILDS NERVOUS SYSTEM (2003)
Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data
C Ramakers et al.
NEUROSCIENCE LETTERS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction
D Teis et al.
DEVELOPMENTAL CELL (2002)
Neuropathology of tuberous sclerosis
M Mizuguchi et al.
BRAIN & DEVELOPMENT (2001)
A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold MP1 on a late endosomal/lysosomal compartment
W Wunderlich et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
